Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
With a market cap of 563.98B, Johnson & Johnson(JNJ) trades at $233.50. The stock has a price-to-earnings ratio of 27.08 and currently yields dividends of 2.2%.
On 2026-04-18, Johnson & Johnson(JNJ) stock traded between a low of $232.04 and a high of $235.54. Shares are currently priced at $233.50, which is +0.6% above the low and -0.9% below the high.
Johnson & Johnson(JNJ) shares are trading with a volume of 8.91M, against a daily average of 7.51M.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $251.71 and a 52-week low of $146.12.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $251.71 and a 52-week low of $146.12.
JNJ News
Key Points Johnson & Johnson exceeded expectations in its Q1 2026 earnings report. Investors weren't blown away by the results. The stock price is down over...
If you are wondering whether Johnson & Johnson at around US$234.54 is still reasonably priced or already rich, the next sections will help you size up the stock...
This week's dividend activity included increased payouts from Johnson & Johnson (JNJ) and Costco (COST) as well as declarations from companies such Texas Instru...
Analyst ratings
59%
of 29 ratingsMore JNJ News
The FDA approved an sBLA submitted by Johnson & Johnson’s Janssen Biotech for the addition of an indication for the treatment of pediatric patients 2 years and...
Johnson & Johnson (JNJ 1.83%) has raised its dividend annually for 64 consecutive years. That makes it a Dividend King, the elite title given to stocks that hav...
In April 2026, Johnson & Johnson reported first-quarter sales of US$24,062 million versus US$21,893 million a year earlier, alongside a quarterly dividend incre...
XLRP is a severe, progressive genetic eye disease causing early-onset night blindness and peripheral vision loss, leading to legal blindness by age 40–45. Meira...
Johnson & Johnson (NYSE:JNJ) on Tuesday posted upbeat earnings for the first quarter. The company reported first-quarter 2025 adjusted earnings of $2.70 per sh...
Johnson & Johnson ((JNJ)) has held its Q1 earnings call. Read on for the main highlights of the call. Claim 30% Off TipRanks Unlock hedge fund-level data and po...
Johnson & Johnson on Tuesday validated our decision to make it our newest Club stock, delivering a beat-and-raise quarter led by its most important growth medic...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.